Piramal Pharma reports consolidated net loss of Rs 136.19 crore in Q3

29 Jan 2026 Evaluate

Piramal Pharma has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 8.51% rise in its net profit at Rs 128.91 crore for the third quarter ended December 31, 2025 as compared to Rs 118.80 crore for the same quarter in the previous year. Total income of the company increased by 1.49% at Rs 1,291.96 crore for Q3FY26 as compared to Rs 1,273.02 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net loss of Rs 136.19 crore for the third quarter ended December 31, 2025 as compared to net profit of Rs 3.68 crore for the same quarter in the previous year. Total income of the company decreased by 1.50% at Rs 2,183.11 crore for Q3FY26 as compared to Rs 2,216.35 crore for the corresponding quarter previous year.

Piramal Pharma Share Price

151.60 -2.95 (-1.91%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×